Amylyx Pharmaceuticals ($AMLX) Insider Trading & Smart Money Activity

Amylyx Pharmaceuticals, Inc. · Drug Manufacturers - Specialty & Generic · Latest filing Oct 5, 2026

Amylyx Pharmaceuticals, Inc. ($AMLX) has 1 insider trade and 2 analyst ratings on file. In the last 12 months on the open market, no insider bought and 1 insider sold ($830.90K), net -$830.90K.

Insider buyers (12 mo)

0

Insider sellers (12 mo)

1

Net insider $ (12 mo)

-$830.90K

Congress trades (12 mo)

0

13F moves on file

0

Analyst ratings on file

2

AMLX insider buying and selling by quarter

Quarter	Insider buys	Insider sales	Congress buys / sales	13F added / cut
Q1 2026	0	0	0 / 0	0 / 0
Q2 2026	0	0	0 / 0	0 / 0
Q3 2026	0	0	0 / 0	0 / 0
Q4 2026	0	1 · $830.90K	0 / 0	0 / 0

Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.

All AMLX insider, congress, 13F and analyst activity

All Insiders Analysts

Date	Source	Who	Action	Shares	Value / amount	ΔOwn	1W	1M	6M	Filing	Story
Oct 5, 2026	Insider	Milne George M JRDirector	Sell (Open-market sale) 10b5-1	30K sh	$830.90K		-1.1%				—
Jun 25, 2026	Analyst	Guggenheim	Reiterates to buy		PT $40		+4.8%	+11.8%			Read
Jun 25, 2026	Analyst	Guggenheim	Reiterates to buy		PT $40		+4.8%	+11.8%			Read

1W / 1M / 6M = how AMLX moved from the trade or filing date.

Insider trading in AMLX: who is buying and selling

Insider	Role	Trades	Open-market net	Shares held	Last trade
Milne George M JR	Director	1	-$830.90K		Oct 5, 2026

Analyst ratings on AMLX

Date	Firm	Action	Rating	Price target	1W	1M	6M	Story
Jun 25, 2026	Guggenheim	Reiterates	buy	$40	+4.8%	+11.8%		Read
Jun 25, 2026	Guggenheim	Reiterates	buy	$40	+4.8%	+11.8%		Read

Frequently asked questions

Are AMLX insiders buying or selling?

Over the last 12 months 0 insiders made 0 open-market purchases worth $0 and 1 insider made 1 open-market sale worth $830.90K, a net -$830.90K.

What is the latest insider trade in AMLX?

Milne George M JR, Director filed a sell (open-market sale) of 30K sh worth $830.90K on Oct 5, 2026.

Other drug manufacturers - specialty & generic stocks

• $INDV
• $LQDA
• $BCRX
• $KNSA
• $PRGO
• $LNTH
• $ANIP
• $ETON

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.